While CREST-2 can stand as a guideline for understanding ACS therapies in case-by-case scenarios, it's critical that trial conclusions do not replace clinical judgment and years of previous research.
Cardiology, in particular, offers a clear view into why so many AI solutions struggle to scale and what differentiates those that are poised for adoption.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
Called RecoverX, the company will leverage AI to mine evidence-based research, medical charts, patient conversations and test results and provide clinical insights for clinicians in real time.
Health IT company Apervita will leverage Diameter Health's capabilities — which include cleaning and enriching clinical data — to enhance data quality for stakeholders looking to create value-based care contracts.
Clinical 2021 is US and EU pharma’s leading event for clinical innovators - join 500+ executive attendees from across the globe to meet and learn virtually.